Atomoxetine for suppression of vasovagal syncope

ConclusionsIn this case series, atomoxetine was a promising oral agent for the prevention of vasovagal syncope. The Poisson distribution permits individual patient-level assessment of improvement and detects insufficient follow-up despite apparent improvement.

Source: Clinical Autonomic Research - February 1, 2023 Category: Research Source Type: research